BCAL Diagnostics

BCAL Diagnostics EBIT Margin

The EBIT Margin (Operating Margin) of BCAL Diagnostics (BDX.AX) as of Oct 17, 2026 is -249.20 %. In the previous year, EBIT Margin (Operating Margin) was -199.31 % — a change of 25.03% (lower).

EBIT Margin

-249.20 %

YoY

25.03%

Last updated:

EBIT Margin (Operating Margin) of BCAL Diagnostics is 2025 -249.20 % . EBIT Margin (Operating Margin) of BCAL Diagnostics was 2024 -199.31 % . It decreases by 25.03% lower compared to the previous year.

For BCAL Diagnostics, the operating (EBIT) margin of -249.2% is up versus -340.1% a few years ago.

The BCAL Diagnostics EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
-192.00 AUD
Jan 1, 2019
-166.32 AUD
Jan 1, 2020
-157.81 AUD
Jan 1, 2021
-340.07 AUD
Jan 1, 2022
-459.21 AUD
Jan 1, 2023
-175.47 AUD
Jan 1, 2024
-199.31 AUD
Jan 1, 2025
-249.20 AUD
The BCAL Diagnostics EBIT Margin history
YEAREBIT MarginYoY
-249.20 %+25.03%
-199.31 %+13.59%
-175.47 %-61.79%
-459.21 %+35.03%
-340.07 %+115.49%
-157.81 %-5.11%
-166.32 %-13.38%
-192.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

BCAL Diagnostics Stock analysis

What does BCAL Diagnostics do? BCAL Diagnostics Ltd, based in Sydney, Australia, operates in the Health Care sector within the Biotechnology industry. The company develops innovative blood screening tests for early breast cancer detection, focusing on a lipid biomarker-based approach known as the BCAL test. This technology complements existing imaging methods like mammograms and aims to support screening and monitoring for women of all ages and backgrounds. BCAL Diagnostics has partnered with Precion Inc. to advance clinical trials and regulatory approvals for its diagnostic solutions. BCAL Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BCAL Diagnostics stock

EBIT Margin (Operating Margin) of BCAL Diagnostics is -249.20 % in 2025.

EBIT Margin (Operating Margin) of BCAL Diagnostics changed from -199.31 % to -249.20 %, representing a 25.03% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) BCAL Diagnostics since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s BCAL Diagnostics with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — BCAL Diagnostics

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — BCAL Diagnostics